Up next
Author
Tags
Share article
The post has been shared by 0 people.
Facebook 0
Twitter 0
Pinterest 0
Mail 0

The recent $12 billion acquisition of Kite Pharma, Inc. by big-pharma giant, Gilead Sciences has biotech investors hungry for the next big buyout target, which could be…

*Click To Read The Full Article*

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
1 comment
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Legislature Addresses Ohio’s Unconstitutional Medical Marijuana Law

Unconstitutional portions of the Ohio medical marijuana law, which had set aside…

A Presidential Candidate Could Be on The Brink of Supporting the End of Prohibition

  United States Senator Sanders, who was recently identified as a “socialist…